The global market for Nasal Spray Live Attenuated Influenza Vaccine is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Nasal Spray Live Attenuated Influenza Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Nasal Spray Live Attenuated Influenza Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Nasal Spray Live Attenuated Influenza Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Nasal Spray Live Attenuated Influenza Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Nasal Spray Live Attenuated Influenza Vaccine players cover Sanofi Pasteur, AstraZeneca, CSL, Abbott and GlaxoSmithKline, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Nasal Spray Live Attenuated Influenza Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Nasal Spray Live Attenuated Influenza Vaccine market, with both quantitative and qualitative data, to help readers understand how the Nasal Spray Live Attenuated Influenza Vaccine market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Nasal Spray Live Attenuated Influenza Vaccine market and forecasts the market size by Type (Trivalent Flu Vaccine and Quadrivalent Flu Vaccine,), by Application (Hospital, Clinic, Public Health Agency and Other), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Trivalent Flu Vaccine
Quadrivalent Flu Vaccine
Segmentation by application
Hospital
Clinic
Public Health Agency
Other
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Sanofi Pasteur
AstraZeneca
CSL
Abbott
GlaxoSmithKline
Serum Institute
Fluenz Tetra
BioDiem
FluMist
ChangChun High & New Technology
BCHT Biotechnology
Chapter Introduction
Chapter 1: Scope of Nasal Spray Live Attenuated Influenza Vaccine, Research Methodology, etc.
Chapter 2: Executive Summary, global Nasal Spray Live Attenuated Influenza Vaccine market size (sales and revenue) and CAGR, Nasal Spray Live Attenuated Influenza Vaccine market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Nasal Spray Live Attenuated Influenza Vaccine sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Nasal Spray Live Attenuated Influenza Vaccine sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Nasal Spray Live Attenuated Influenza Vaccine market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Sanofi Pasteur, AstraZeneca, CSL, Abbott, GlaxoSmithKline, Serum Institute, Fluenz Tetra, BioDiem and FluMist, etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nasal Spray Live Attenuated Influenza Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Nasal Spray Live Attenuated Influenza Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Nasal Spray Live Attenuated Influenza Vaccine by Country/Region, 2017, 2022 & 2028
2.2 Nasal Spray Live Attenuated Influenza Vaccine Segment by Type
2.2.1 Trivalent Flu Vaccine
2.2.2 Quadrivalent Flu Vaccine
2.3 Nasal Spray Live Attenuated Influenza Vaccine Sales by Type
2.3.1 Global Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global Nasal Spray Live Attenuated Influenza Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Nasal Spray Live Attenuated Influenza Vaccine Sale Price by Type (2017-2022)
2.4 Nasal Spray Live Attenuated Influenza Vaccine Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Public Health Agency
2.4.4 Other
2.5 Nasal Spray Live Attenuated Influenza Vaccine Sales by Application
2.5.1 Global Nasal Spray Live Attenuated Influenza Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global Nasal Spray Live Attenuated Influenza Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Nasal Spray Live Attenuated Influenza Vaccine Sale Price by Application (2017-2022)
3 Global Nasal Spray Live Attenuated Influenza Vaccine by Company
3.1 Global Nasal Spray Live Attenuated Influenza Vaccine Breakdown Data by Company
3.1.1 Global Nasal Spray Live Attenuated Influenza Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Company (2020-2022)
3.2 Global Nasal Spray Live Attenuated Influenza Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global Nasal Spray Live Attenuated Influenza Vaccine Revenue by Company (2020-2022)
3.2.2 Global Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global Nasal Spray Live Attenuated Influenza Vaccine Sale Price by Company
3.4 Key Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Product Location Distribution
3.4.2 Players Nasal Spray Live Attenuated Influenza Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Nasal Spray Live Attenuated Influenza Vaccine by Geographic Region
4.1 World Historic Nasal Spray Live Attenuated Influenza Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global Nasal Spray Live Attenuated Influenza Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Nasal Spray Live Attenuated Influenza Vaccine Annual Revenue by Geographic Region
4.2 World Historic Nasal Spray Live Attenuated Influenza Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global Nasal Spray Live Attenuated Influenza Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Nasal Spray Live Attenuated Influenza Vaccine Annual Revenue by Country/Region
4.3 Americas Nasal Spray Live Attenuated Influenza Vaccine Sales Growth
4.4 APAC Nasal Spray Live Attenuated Influenza Vaccine Sales Growth
4.5 Europe Nasal Spray Live Attenuated Influenza Vaccine Sales Growth
4.6 Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Sales Growth
5 Americas
5.1 Americas Nasal Spray Live Attenuated Influenza Vaccine Sales by Country
5.1.1 Americas Nasal Spray Live Attenuated Influenza Vaccine Sales by Country (2017-2022)
5.1.2 Americas Nasal Spray Live Attenuated Influenza Vaccine Revenue by Country (2017-2022)
5.2 Americas Nasal Spray Live Attenuated Influenza Vaccine Sales by Type
5.3 Americas Nasal Spray Live Attenuated Influenza Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nasal Spray Live Attenuated Influenza Vaccine Sales by Region
6.1.1 APAC Nasal Spray Live Attenuated Influenza Vaccine Sales by Region (2017-2022)
6.1.2 APAC Nasal Spray Live Attenuated Influenza Vaccine Revenue by Region (2017-2022)
6.2 APAC Nasal Spray Live Attenuated Influenza Vaccine Sales by Type
6.3 APAC Nasal Spray Live Attenuated Influenza Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Nasal Spray Live Attenuated Influenza Vaccine by Country
7.1.1 Europe Nasal Spray Live Attenuated Influenza Vaccine Sales by Country (2017-2022)
7.1.2 Europe Nasal Spray Live Attenuated Influenza Vaccine Revenue by Country (2017-2022)
7.2 Europe Nasal Spray Live Attenuated Influenza Vaccine Sales by Type
7.3 Europe Nasal Spray Live Attenuated Influenza Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine by Country
8.1.1 Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Sales by Type
8.3 Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nasal Spray Live Attenuated Influenza Vaccine
10.3 Manufacturing Process Analysis of Nasal Spray Live Attenuated Influenza Vaccine
10.4 Industry Chain Structure of Nasal Spray Live Attenuated Influenza Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nasal Spray Live Attenuated Influenza Vaccine Distributors
11.3 Nasal Spray Live Attenuated Influenza Vaccine Customer
12 World Forecast Review for Nasal Spray Live Attenuated Influenza Vaccine by Geographic Region
12.1 Global Nasal Spray Live Attenuated Influenza Vaccine Market Size Forecast by Region
12.1.1 Global Nasal Spray Live Attenuated Influenza Vaccine Forecast by Region (2023-2028)
12.1.2 Global Nasal Spray Live Attenuated Influenza Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Nasal Spray Live Attenuated Influenza Vaccine Forecast by Type
12.7 Global Nasal Spray Live Attenuated Influenza Vaccine Forecast by Application
13 Key Players Analysis
13.1 Sanofi Pasteur
13.1.1 Sanofi Pasteur Company Information
13.1.2 Sanofi Pasteur Nasal Spray Live Attenuated Influenza Vaccine Product Offered
13.1.3 Sanofi Pasteur Nasal Spray Live Attenuated Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Sanofi Pasteur Main Business Overview
13.1.5 Sanofi Pasteur Latest Developments
13.2 AstraZeneca
13.2.1 AstraZeneca Company Information
13.2.2 AstraZeneca Nasal Spray Live Attenuated Influenza Vaccine Product Offered
13.2.3 AstraZeneca Nasal Spray Live Attenuated Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 AstraZeneca Main Business Overview
13.2.5 AstraZeneca Latest Developments
13.3 CSL
13.3.1 CSL Company Information
13.3.2 CSL Nasal Spray Live Attenuated Influenza Vaccine Product Offered
13.3.3 CSL Nasal Spray Live Attenuated Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 CSL Main Business Overview
13.3.5 CSL Latest Developments
13.4 Abbott
13.4.1 Abbott Company Information
13.4.2 Abbott Nasal Spray Live Attenuated Influenza Vaccine Product Offered
13.4.3 Abbott Nasal Spray Live Attenuated Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Abbott Main Business Overview
13.4.5 Abbott Latest Developments
13.5 GlaxoSmithKline
13.5.1 GlaxoSmithKline Company Information
13.5.2 GlaxoSmithKline Nasal Spray Live Attenuated Influenza Vaccine Product Offered
13.5.3 GlaxoSmithKline Nasal Spray Live Attenuated Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 GlaxoSmithKline Main Business Overview
13.5.5 GlaxoSmithKline Latest Developments
13.6 Serum Institute
13.6.1 Serum Institute Company Information
13.6.2 Serum Institute Nasal Spray Live Attenuated Influenza Vaccine Product Offered
13.6.3 Serum Institute Nasal Spray Live Attenuated Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Serum Institute Main Business Overview
13.6.5 Serum Institute Latest Developments
13.7 Fluenz Tetra
13.7.1 Fluenz Tetra Company Information
13.7.2 Fluenz Tetra Nasal Spray Live Attenuated Influenza Vaccine Product Offered
13.7.3 Fluenz Tetra Nasal Spray Live Attenuated Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Fluenz Tetra Main Business Overview
13.7.5 Fluenz Tetra Latest Developments
13.8 BioDiem
13.8.1 BioDiem Company Information
13.8.2 BioDiem Nasal Spray Live Attenuated Influenza Vaccine Product Offered
13.8.3 BioDiem Nasal Spray Live Attenuated Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 BioDiem Main Business Overview
13.8.5 BioDiem Latest Developments
13.9 FluMist
13.9.1 FluMist Company Information
13.9.2 FluMist Nasal Spray Live Attenuated Influenza Vaccine Product Offered
13.9.3 FluMist Nasal Spray Live Attenuated Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 FluMist Main Business Overview
13.9.5 FluMist Latest Developments
13.10 ChangChun High & New Technology
13.10.1 ChangChun High & New Technology Company Information
13.10.2 ChangChun High & New Technology Nasal Spray Live Attenuated Influenza Vaccine Product Offered
13.10.3 ChangChun High & New Technology Nasal Spray Live Attenuated Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 ChangChun High & New Technology Main Business Overview
13.10.5 ChangChun High & New Technology Latest Developments
13.11 BCHT Biotechnology
13.11.1 BCHT Biotechnology Company Information
13.11.2 BCHT Biotechnology Nasal Spray Live Attenuated Influenza Vaccine Product Offered
13.11.3 BCHT Biotechnology Nasal Spray Live Attenuated Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 BCHT Biotechnology Main Business Overview
13.11.5 BCHT Biotechnology Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Nasal Spray Live Attenuated Influenza Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Nasal Spray Live Attenuated Influenza Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Trivalent Flu Vaccine
Table 4. Major Players of Quadrivalent Flu Vaccine
Table 5. Global Nasal Spray Live Attenuated Influenza Vaccine Sales by Type (2017-2022) & (K Units)
Table 6. Global Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Type (2017-2022)
Table 7. Global Nasal Spray Live Attenuated Influenza Vaccine Revenue by Type (2017-2022) & ($ million)
Table 8. Global Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share by Type (2017-2022)
Table 9. Global Nasal Spray Live Attenuated Influenza Vaccine Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Nasal Spray Live Attenuated Influenza Vaccine Sales by Application (2017-2022) & (K Units)
Table 11. Global Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Application (2017-2022)
Table 12. Global Nasal Spray Live Attenuated Influenza Vaccine Revenue by Application (2017-2022)
Table 13. Global Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share by Application (2017-2022)
Table 14. Global Nasal Spray Live Attenuated Influenza Vaccine Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Nasal Spray Live Attenuated Influenza Vaccine Sales by Company (2020-2022) & (K Units)
Table 16. Global Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Company (2020-2022)
Table 17. Global Nasal Spray Live Attenuated Influenza Vaccine Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share by Company (2020-2022)
Table 19. Global Nasal Spray Live Attenuated Influenza Vaccine Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Nasal Spray Live Attenuated Influenza Vaccine Producing Area Distribution and Sales Area
Table 21. Players Nasal Spray Live Attenuated Influenza Vaccine Products Offered
Table 22. Nasal Spray Live Attenuated Influenza Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Nasal Spray Live Attenuated Influenza Vaccine Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share Geographic Region (2017-2022)
Table 27. Global Nasal Spray Live Attenuated Influenza Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Nasal Spray Live Attenuated Influenza Vaccine Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Country/Region (2017-2022)
Table 31. Global Nasal Spray Live Attenuated Influenza Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Nasal Spray Live Attenuated Influenza Vaccine Sales by Country (2017-2022) & (K Units)
Table 34. Americas Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Country (2017-2022)
Table 35. Americas Nasal Spray Live Attenuated Influenza Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share by Country (2017-2022)
Table 37. Americas Nasal Spray Live Attenuated Influenza Vaccine Sales by Type (2017-2022) & (K Units)
Table 38. Americas Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Type (2017-2022)
Table 39. Americas Nasal Spray Live Attenuated Influenza Vaccine Sales by Application (2017-2022) & (K Units)
Table 40. Americas Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Application (2017-2022)
Table 41. APAC Nasal Spray Live Attenuated Influenza Vaccine Sales by Region (2017-2022) & (K Units)
Table 42. APAC Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Region (2017-2022)
Table 43. APAC Nasal Spray Live Attenuated Influenza Vaccine Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share by Region (2017-2022)
Table 45. APAC Nasal Spray Live Attenuated Influenza Vaccine Sales by Type (2017-2022) & (K Units)
Table 46. APAC Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Type (2017-2022)
Table 47. APAC Nasal Spray Live Attenuated Influenza Vaccine Sales by Application (2017-2022) & (K Units)
Table 48. APAC Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Application (2017-2022)
Table 49. Europe Nasal Spray Live Attenuated Influenza Vaccine Sales by Country (2017-2022) & (K Units)
Table 50. Europe Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Country (2017-2022)
Table 51. Europe Nasal Spray Live Attenuated Influenza Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share by Country (2017-2022)
Table 53. Europe Nasal Spray Live Attenuated Influenza Vaccine Sales by Type (2017-2022) & (K Units)
Table 54. Europe Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Type (2017-2022)
Table 55. Europe Nasal Spray Live Attenuated Influenza Vaccine Sales by Application (2017-2022) & (K Units)
Table 56. Europe Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Nasal Spray Live Attenuated Influenza Vaccine
Table 66. Key Market Challenges & Risks of Nasal Spray Live Attenuated Influenza Vaccine
Table 67. Key Industry Trends of Nasal Spray Live Attenuated Influenza Vaccine
Table 68. Nasal Spray Live Attenuated Influenza Vaccine Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Nasal Spray Live Attenuated Influenza Vaccine Distributors List
Table 71. Nasal Spray Live Attenuated Influenza Vaccine Customer List
Table 72. Global Nasal Spray Live Attenuated Influenza Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Nasal Spray Live Attenuated Influenza Vaccine Sales Market Forecast by Region
Table 74. Global Nasal Spray Live Attenuated Influenza Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Nasal Spray Live Attenuated Influenza Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Nasal Spray Live Attenuated Influenza Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Nasal Spray Live Attenuated Influenza Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Nasal Spray Live Attenuated Influenza Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Nasal Spray Live Attenuated Influenza Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Nasal Spray Live Attenuated Influenza Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Nasal Spray Live Attenuated Influenza Vaccine Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Nasal Spray Live Attenuated Influenza Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Nasal Spray Live Attenuated Influenza Vaccine Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Nasal Spray Live Attenuated Influenza Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 92. Sanofi Pasteur Basic Information, Nasal Spray Live Attenuated Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Sanofi Pasteur Nasal Spray Live Attenuated Influenza Vaccine Product Offered
Table 94. Sanofi Pasteur Nasal Spray Live Attenuated Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Sanofi Pasteur Main Business
Table 96. Sanofi Pasteur Latest Developments
Table 97. AstraZeneca Basic Information, Nasal Spray Live Attenuated Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. AstraZeneca Nasal Spray Live Attenuated Influenza Vaccine Product Offered
Table 99. AstraZeneca Nasal Spray Live Attenuated Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. AstraZeneca Main Business
Table 101. AstraZeneca Latest Developments
Table 102. CSL Basic Information, Nasal Spray Live Attenuated Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. CSL Nasal Spray Live Attenuated Influenza Vaccine Product Offered
Table 104. CSL Nasal Spray Live Attenuated Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. CSL Main Business
Table 106. CSL Latest Developments
Table 107. Abbott Basic Information, Nasal Spray Live Attenuated Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Abbott Nasal Spray Live Attenuated Influenza Vaccine Product Offered
Table 109. Abbott Nasal Spray Live Attenuated Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Abbott Main Business
Table 111. Abbott Latest Developments
Table 112. GlaxoSmithKline Basic Information, Nasal Spray Live Attenuated Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. GlaxoSmithKline Nasal Spray Live Attenuated Influenza Vaccine Product Offered
Table 114. GlaxoSmithKline Nasal Spray Live Attenuated Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. GlaxoSmithKline Main Business
Table 116. GlaxoSmithKline Latest Developments
Table 117. Serum Institute Basic Information, Nasal Spray Live Attenuated Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. Serum Institute Nasal Spray Live Attenuated Influenza Vaccine Product Offered
Table 119. Serum Institute Nasal Spray Live Attenuated Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Serum Institute Main Business
Table 121. Serum Institute Latest Developments
Table 122. Fluenz Tetra Basic Information, Nasal Spray Live Attenuated Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. Fluenz Tetra Nasal Spray Live Attenuated Influenza Vaccine Product Offered
Table 124. Fluenz Tetra Nasal Spray Live Attenuated Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Fluenz Tetra Main Business
Table 126. Fluenz Tetra Latest Developments
Table 127. BioDiem Basic Information, Nasal Spray Live Attenuated Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 128. BioDiem Nasal Spray Live Attenuated Influenza Vaccine Product Offered
Table 129. BioDiem Nasal Spray Live Attenuated Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. BioDiem Main Business
Table 131. BioDiem Latest Developments
Table 132. FluMist Basic Information, Nasal Spray Live Attenuated Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 133. FluMist Nasal Spray Live Attenuated Influenza Vaccine Product Offered
Table 134. FluMist Nasal Spray Live Attenuated Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. FluMist Main Business
Table 136. FluMist Latest Developments
Table 137. ChangChun High & New Technology Basic Information, Nasal Spray Live Attenuated Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 138. ChangChun High & New Technology Nasal Spray Live Attenuated Influenza Vaccine Product Offered
Table 139. ChangChun High & New Technology Nasal Spray Live Attenuated Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. ChangChun High & New Technology Main Business
Table 141. ChangChun High & New Technology Latest Developments
Table 142. BCHT Biotechnology Basic Information, Nasal Spray Live Attenuated Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 143. BCHT Biotechnology Nasal Spray Live Attenuated Influenza Vaccine Product Offered
Table 144. BCHT Biotechnology Nasal Spray Live Attenuated Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. BCHT Biotechnology Main Business
Table 146. BCHT Biotechnology Latest Developments
List of Figures
Figure 1. Picture of Nasal Spray Live Attenuated Influenza Vaccine
Figure 2. Nasal Spray Live Attenuated Influenza Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nasal Spray Live Attenuated Influenza Vaccine Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Nasal Spray Live Attenuated Influenza Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Nasal Spray Live Attenuated Influenza Vaccine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Trivalent Flu Vaccine
Figure 10. Product Picture of Quadrivalent Flu Vaccine
Figure 11. Global Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Type in 2021
Figure 12. Global Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share by Type (2017-2022)
Figure 13. Nasal Spray Live Attenuated Influenza Vaccine Consumed in Hospital
Figure 14. Global Nasal Spray Live Attenuated Influenza Vaccine Market: Hospital (2017-2022) & (K Units)
Figure 15. Nasal Spray Live Attenuated Influenza Vaccine Consumed in Clinic
Figure 16. Global Nasal Spray Live Attenuated Influenza Vaccine Market: Clinic (2017-2022) & (K Units)
Figure 17. Nasal Spray Live Attenuated Influenza Vaccine Consumed in Public Health Agency
Figure 18. Global Nasal Spray Live Attenuated Influenza Vaccine Market: Public Health Agency (2017-2022) & (K Units)
Figure 19. Nasal Spray Live Attenuated Influenza Vaccine Consumed in Other
Figure 20. Global Nasal Spray Live Attenuated Influenza Vaccine Market: Other (2017-2022) & (K Units)
Figure 21. Global Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Application (2017-2022)
Figure 22. Global Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share by Application in 2021
Figure 23. Nasal Spray Live Attenuated Influenza Vaccine Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share by Company in 2021
Figure 25. Global Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share by Geographic Region in 2021
Figure 27. Global Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Region (2017-2022)
Figure 28. Global Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share by Country/Region in 2021
Figure 29. Americas Nasal Spray Live Attenuated Influenza Vaccine Sales 2017-2022 (K Units)
Figure 30. Americas Nasal Spray Live Attenuated Influenza Vaccine Revenue 2017-2022 ($ Millions)
Figure 31. APAC Nasal Spray Live Attenuated Influenza Vaccine Sales 2017-2022 (K Units)
Figure 32. APAC Nasal Spray Live Attenuated Influenza Vaccine Revenue 2017-2022 ($ Millions)
Figure 33. Europe Nasal Spray Live Attenuated Influenza Vaccine Sales 2017-2022 (K Units)
Figure 34. Europe Nasal Spray Live Attenuated Influenza Vaccine Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Sales 2017-2022 (K Units)
Figure 36. Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Revenue 2017-2022 ($ Millions)
Figure 37. Americas Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Country in 2021
Figure 38. Americas Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share by Country in 2021
Figure 39. United States Nasal Spray Live Attenuated Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Nasal Spray Live Attenuated Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Nasal Spray Live Attenuated Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Nasal Spray Live Attenuated Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Region in 2021
Figure 44. APAC Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share by Regions in 2021
Figure 45. China Nasal Spray Live Attenuated Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Nasal Spray Live Attenuated Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Nasal Spray Live Attenuated Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Nasal Spray Live Attenuated Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Nasal Spray Live Attenuated Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Nasal Spray Live Attenuated Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Country in 2021
Figure 52. Europe Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share by Country in 2021
Figure 53. Germany Nasal Spray Live Attenuated Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Nasal Spray Live Attenuated Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Nasal Spray Live Attenuated Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Nasal Spray Live Attenuated Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Nasal Spray Live Attenuated Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Nasal Spray Live Attenuated Influenza Vaccine Revenue Market Share by Country in 2021
Figure 60. Egypt Nasal Spray Live Attenuated Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Nasal Spray Live Attenuated Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Nasal Spray Live Attenuated Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Nasal Spray Live Attenuated Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Nasal Spray Live Attenuated Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)